04/28/2022
Dr. Kolb confirms: It is definitely FUS-ALS. This initial consultation was perfect and Jacob met every qualification to be in the clinical trial, sponsored by Ionis Pharmaceuticals. We only need the sponsor's approval to join the program.
No comments:
Post a Comment